Bora Pharmaceuticals Co. Ltd. (6472)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
423. 50
-7.5
-1.7401%
NT$
- Market Cap
- P/E Ratio
- Div Yield
765,281 Volume
- Eps
NT$ 431
Previous Close Want to track 6472 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bora Pharmaceuticals Co. Ltd. (6472) Statistics
Valuation metrics
Market Cap -
Enterprise value 65.86B
Trailing P/E (ttm) 32.47
Forward P/E -
PEG ratio -0.49
Price/Sales (ttm) 2.87
Price/Book (mrq) 3.65
Enterprise Value/Revenue 3.55
Enterprise Value/EBITDA 17.79
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 769.88K
Average volume (90 days) 1.42M
Price summary
52-Week low 330.5
52-Week high 795
Beta -
50-Day moving average 407.8
200-Day moving average 435.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 10
Trailing annual dividend yield 0.024%
5-Year annual dividend yield -
Payout ratio 0.9
Dividend Date -
Ex-Dividend Date -
Last split factor 1,199:1,000
Last split Date 4 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.09%
Operating margin 0.16%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 145.6
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 12.63
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 38.41
Total debt (mrq) -
Total Debt/Equity (mrq) 1.2
Current ratio (mrq) 1.38%
Book value per share (mrq) 130.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
